UnitedHealthcare will provide at-risk patients with 200,000 kits that include Tamiflu, a digital thermometer and a P.C.R. coronavirus diagnostic test. The kits will go to the insurer’s MedAdvantage plan members, with the main focus being on people at highest risk of COVID-19 and flu complications based on their age and health status. (The New York Times

The COVID-19 vaccine being developed by the University of Oxford and AstraZeneca produces a similar immune response in older and younger adults, with adverse responses being lower among the elderly. That an immune response happened in older people would be positive, since the immune system weakens with age and leaves elderly people at highest risk of dying from the virus. (Reuters)

Although the Trump Administration is allowing pharmacies to give the flu vaccine to children as young as three years old, many pharmacies are refusing to do so. A new report about a phone call survey of 175 pharmacies and discussions with large pharmacy chains reveals that the vast majority of the pharmacies aren’t going to give the vaccine to children that young. (CNN)

The United Kingdom is considering reducing the self-isolation for contacts of people who tested positive for the coronavirus from two weeks to 10 or seven days.  As it is, a Kings College study shows that Britons have largely failed to comply with their country’s quarantine roles; only 10.9% of 30,000 people tracked by the study between March and August said they had stayed at home and quarantined for a full two weeks after being contact traced. (Bloomberg)

Deloitte’s David Betts and Chris Zant join MM+M’s Larry Dobrow to discuss the evolution in the way consultancies like Deloitte are working with life-sciences clients. Listen to the full The MM+M Podcast episode to learn more. (MM+M)